Ticlopidine, platelets, and vascular disease

From the contents: W.K. Hass, J.D. Easton: On the Proximate Causal Mechanisms of Ischemic Stroke and Myocardial Infarction.- E. Panak: A Review of Ticlopidine Development.- P. Teitelbaum: Pharmacokinetics and Pharmacodynamics of Ticlopidine in Animals and Man.- L.A. Harker: The Unique Mechanism of Action of Ticlopidine on Human Platelets in Contrast to Other Antiplatelet Agents.- W. Pryse-Phillips: Clinical Studies of Stroke Prevention with Ticlopidine in Man.- L. Janzon: Clinical Trials of Ticlopidine in Patients with Intermittent Claudication.- F. Balsano: Clinical Trials of Ticlopidine in Patients with Coronary Artery Disease.- M.L. Dyken: Systematic Overviews of Randomized Trials of Antiplatelet Agents for Prevention of Stroke, Mycocardial Infarction and Vascular Death.- V. Molony: An Analysis of the Side Effects of Ticlopidine.- J.D. Easton: The Role of Ticlopidine in Stroke Prevention: A Cost-Risk-Benefit Analysis.- W.K. Hass: Epilogue: The Virtues of Imperfection.